Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study-Reference-Cited by-同舟云学术

Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study

Published:2021-12 Issue:12 Volume:9 Page:4371-4380.e4
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Nolasco Santi^ORCID,Crimi Claudia,Pelaia Corrado,Benfante Alida,Caiaffa Maria Filomena,Calabrese Cecilia,Carpagnano Giovanna Elisiana,Ciotta Domenico,D'Amato Maria,Macchia Luigi,Pelaia Girolamo,Pellegrino Simona,Scichilone Nicola,Scioscia Giulia,Spadaro Giuseppe,Campisi Raffaele,Valenti Giuseppe,Vatrella Alessandro,Crimi Nunzio

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference52 articles.

1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur Respir J,2014

2. 2019 GINA report: Global Strategy for Asthma Management and Prevention;Global Initiative for Asthma,2019

3. Managing comorbid conditions in severe asthma;Bardin;Med J Aust,2018

4. Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities;Crimi;World Allergy Organ J,2020

5. The severe Asthma Network in Italy: findings and perspectives;Heffler;J Allergy Clin Immunol Pract,2019

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of biological therapies on laboratory outcomes and FEV1 in patients with severe eosinophilic asthma with chronic rhinosinusitis: a real-life study from Saudi Arabia;Multidisciplinary Respiratory Medicine;2024-09-09

2. Real-Life Clinical Outcomes of Benralizumab Treatment in Patients with Uncontrolled Severe Asthma and Coexisting Chronic Rhinosinusitis with Nasal Polyposis;Journal of Clinical Medicine;2024-07-20

3. Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis;Respirology;2024-06-07

4. Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study;Journal of Clinical Medicine;2024-05-20

5. Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo‐controlled OSTRO trial;British Journal of Clinical Pharmacology;2024-05-07